|
Home
>
Newsletters
>
International Pharmaceutical Regulatory Monitor
> EMEA Advises on Clinical Trials of Treatments for Sepsis, Three Other Conditions
International Pharmaceutical Regulatory Monitor
July 2006
| Vol.
34 No.
7
EMEA Advises on Clinical Trials of Treatments for Sepsis, Three Other Conditions
The European Medicines Agency (EMEA) has issued separate guidelines on clinical investigations of medicinal products used in the treatment of sepsis and weight control, as well as two other major medical conditions. |
ePublishing :: CMS, Hosting & Web Development | © Copyright by FDAnews
All rights reserved. Do not duplicate or redistribute in any form.